FindTrial
Sign In

The prevalence of osteoporosis after liver transplantation, risk factors and prediction tool

The prevalence of osteoporosis after liver transplantation, risk factors and prediction tool

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ECS-12002431
Enrollment
Unknown
Registered
2012-08-19
Start date
2012-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self-financing

Interventions

1:no

Sponsors

The General Hospital of Chinese People's Armed Police Forces
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Liver transplant recipient; 2. Age of 20-70 years; 3. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation; 2. Other organ transplantation; 3. Subjects once treated with Alendronate, Sr salt, Sex hormones or Parathormone; 4. Patients with delirium or dementia, who cannot obtain informed consent; 5. Not suitable for clinical trials because of other reasons.

Design outcomes

Primary

MeasureTime frame
Bone mineral density;—

Secondary

MeasureTime frame
beta-cross laps (CTX);Total type I procollagen N-terminal peptide (P1NP);Parathormone (PTH);Blood glucose;Vitamin D levels;Calcineurin inhibitors levels;Electrolytes;Renal function;Liver function;—

Countries

China

Contacts

Public ContactXu Chun
wjxuchun@sohu.com+86 10 57976567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026